Having shown that FAK/SRC inhibitors sensitized resistant cell lines to MEKis, we next investigated whether combined MEK/SRC inhibition could reduce cell growth in MEKi-sensitive MPNST cells. Here, SRC is linked to malignant peripheral nerve sheath tumor.